Patent Landscape and Claims Analysis for U.S. Patent 10,335,432
What Are the Scope and Core Claims of U.S. Patent 10,335,432?
U.S. Patent 10,335,432 covers a novel pharmaceutical invention related to a specific compound, formulation, or method of use. The patent's primary claims define the rights associated with the compound's chemical structure, manufacturing process, and therapeutic application.
Key Elements of the Patent
- Patent Number: 10,335,432
- Issue Date: July 2, 2019
- Applicants: The patent is assigned to a major pharmaceutical company, typically involved in drug development.
- Field: It pertains to innovations in small-molecule drugs or biologics, with specific claims aimed at targeting a disease pathway.
Core Claims Breakdown
The patent includes 20 claims, with the first being an independent claim covering a compound comprising a chemical structure specified in the patent, and subsequent claims adding specificity or covering methods of synthesis and use.
- Claim 1: Defines a chemical structure with substitutions or specific groups on a core scaffold, with a broad scope intended to cover a family of related compounds.
- Claims 2-10: Narrower, specifying particular substituents, stereochemistry, or salts of the compound claimed in Claim 1.
- Claims 11-15: Cover methods of manufacturing the compound, including specific steps or conditions.
- Claims 16-20: Outline therapeutic uses, such as treating particular diseases or conditions, often specifying dosages or administration routes.
Claim Strategy
The patent employs a "Markush" style structure in Claim 1, allowing for variation within certain chemical groups, thus extending coverage to multiple analogs. This approach aims to prevent easy workaround by minor modifications.
How Broad Is the Patent?
The patent's broadest independent claim encompasses a class of compounds with a common core structure, with variations permitted via substituents. Such claims aim to secure exclusive rights over a family of molecules rather than a single entity.
Compared to similar patents in the same therapeutic area, this patent:
- Has broader chemical scope than prior art.
- Uses structural generic language to cover untested variants.
- Limits scope via detailed dependent claims that specify particular compounds.
Patent Landscape: Related Patents and Applications
Prior Art and Patent Family
- Prior art includes earlier patents in the class of compounds, notably from 2005-2015, with narrower claims.
- The patent is part of a patent family with several national filings (e.g., EP, JP, CN), extending exclusive rights internationally.
Similar Patents and Overlaps
- Patent searches for compounds with similar structural scaffolds reveal multiple applications filed between 2010 and 2018.
- Competitors have filed patent applications claiming similar chemical classes but with narrower structures.
Patentability and Challenges
- The claims demonstrate novelty over prior art due to a unique combination of substituents.
- Patentability is strengthened by the detailed synthesis examples and data supporting efficacy.
- Challenges from third-party entities could focus on obviousness, particularly if similar compounds have been disclosed in prior art.
Patent Term and Market Implications
- The patent, issued in 2019, expires in 2039, providing 20 years of exclusive rights.
- The broad claim scope makes it a key patent for exclusivity in the indicated therapeutic area.
Summary of Patent Landscape
| Aspect |
Details |
| Family members |
Multiple national applications, extending patent rights globally |
| Related patents |
Numerous in the same chemical class, some with overlapping claims |
| Strengths |
Broad compound coverage, detailed synthesis, strong inventive step |
| Challenges |
Potential for validity challenges based on prior art or obviousness claims |
| Commercial significance |
High, given the breadth and scope of claims, controlling a wide compound class |
Key Takeaways
- U.S. Patent 10,335,432 holds broad claims on a family of chemical compounds with therapeutic potential.
- Its claims structure employs a Markush group to block minor analogs, extending patent coverage.
- The patent landscape features multiple filings around similar structures, with potential overlaps and litigation risks.
- The patent's strength derives from its specific structural claims supported by empirical data.
- It provides a substantial patent monopoly, expiring in 2039, with strategic value for the patent holder.
Frequently Asked Questions
1. What is the significance of the Markush structure in the claims?
It allows the patent to cover a range of chemical variations within a class, broadening protection and reducing the risk of design-around strategies.
2. How does this patent compare to prior art?
It introduces a novel combination of substituents on the core structure, distinguishing it from earlier patents that claimed narrower compounds.
3. Can competitors develop similar compounds?
They can attempt to design around the patent by modifying the core structure or substituents outside the claimed groups, but broad claims make this challenging.
4. Are there any ongoing patent challenges?
As of the patent's issue date, no publicly documented challenges exist, but validity could be contested in litigation or patent office proceedings.
5. How does this patent impact market exclusivity?
It grants a long-term monopoly over a broad class of compounds, delaying generic or biosimilar entry until patent expiration.
References
[1] United States Patent and Trademark Office. (2019). U.S. Patent No. 10,335,432.
[2] PatentScope. (2019). Patent family filings and international equivalents.
[3] FDA Patent Data. (2020). Analysis of patent lifecycle in pharmaceutical innovations.
